← Back to headlines
Sangamo Aims for Fabry BLA Submission by Summer 2026, Advances Neurology Pipeline
Sangamo Therapeutics is targeting summer 2026 for its Fabry BLA submission while continuing to advance its neurology pipeline and engage in partner discussions.
30 Mar, 22:22 — 30 Mar, 22:22
Sources
Showing 1 of 1 sources


